Noteworthy, several recent studies have demonstrated that MCU is also involved in lipid metabolism [8–10]; and lipid accumulation in hepatocytes substantially altered intracellular Ca2+ homeostasis that further enhanced the hepatosteatosis and thereby triggered MASLD progression to HCC [25–28]. Here, MCU is linked to metabolic dysfunction-associated steatotic liver disease.